Clinical case of Cor triatriatum sinister, a dilemma of anticoagulation: A case report and literature review.

Autor: Arzhangzade A; Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Zamirian M; Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Nozhat S; Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran., Shafei S; Skull Base Research Center, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran., Narimani Javid R; Student Research Committee Hamadan University of Medical Sciences Hamadan Iran., Salahi S; Minimally Invasive Surgery Research Center Iran University of Medical Science Tehran Iran., Khorshidi S; Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2024 Jun 25; Vol. 12 (7), pp. e8908. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).
DOI: 10.1002/ccr3.8908
Abstrakt: Cor triatriatum is a rare congenital heart abnormality in which a membrane separates the left atrium (LA; sinister) or the right atrium (dexter) into two compartments. It is also a long-forgotten cause of atrial fibrillation (AF) and substantially higher rates of blood stagnation, particularly proximal to the additional septum in the LA. In this case report, we faced a CHA2DS2-VASc score of 1 in patients with non-valvular AF due to Cor triatriatum sinister (CTS). The decision to start anticoagulants in this particular case was controversial, so we reviewed the literature to assess and address it. We present our case and discuss the indication of anticoagulants in this unique clinical scenario, accompanied by a literature review. Facing this dilemma of starting anticoagulants in special cases of CTS and AF should be individualized and need more investigation. However, till this moment, based on similar reports, it seems to be rational to consider CTS Per se as an additional risk stratification marker beyond the CHA2DS2-VASc score start anticoagulant until the surgical resection. Considering CTS as the sole indication of anticoagulant in patients with normal sinus rhythm is a complex matter that needs further investigation.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje